We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Nanoprinter to Mass-Produce NanoDevices

By Biotechdaily staff writers
Posted on 28 Jun 2005
A new "nano-printing” technique could enable the mass-production of nano-devices manufactured one at a time.

Clearly the most immediate candidate for this technology is the DNA microarray, nano-devices utilized to identify and evaluate genetic disorders including viral illnesses such as AIDs, Alzheimer's disease, and certain kinds of cancer. More...
The capability to generate these complicated devices would make DNA analysis as ordinary and economical as blood testing, thereby significantly speeding up efforts to understand the mechanisms of disease.

The demand for smaller devices of increasing complexity in areas from biomedicine to information technology has prompted several research efforts toward high-resolution, high-throughput nano-printing techniques. Researchers led by Prof. Francesco Stellacci, from the department of materials science and engineering at the Massachusetts Institute of Technology (MIT, Boston, MA, USA) have developed a printing method that is unrivaled in both information content per printing cycle and resolution. They achieved the latter using what Arum Amy Yu, an MIT graduate student and member of the research team, calls "nature's most efficient printing technique: the DNA/RNA information transfer.”

In the new printing technique, called supramolecular nano-stamping (SuNS), single strands of DNA basically self-assemble upon a surface to copy a nano-scale pattern made of their complementary DNA strands. The duplicates are identical to the master and can therefore be used as masters themselves. This increases print output exponentially while enabling the reproduction of very complicated nano-scale patterns.

One of these patterns is found on a DNA microarray, a glass chip or silicon printed with up to 500,000 tiny dots. Each dot is made up of multiple DNA molecules of known sequence, i.e., a snippet of an individual's genetic code. Researchers use DNA microarrays to find and analyze a person's DNA or messenger-RNA genetic code. Frequent, widespread use of these devices is complicated by the fact that producing them is a painstaking process that involves at least 400 printing steps and costs about U.S.$500 per microarray.

MIT's nano-printing technique requires only three steps and could reduce the cost of each microarray to under U.S.$50. "This would completely revolutionize diagnostics,” said Prof. Stellacci. With the ability to mass-produce these devices and thereby make DNA analysis routine, "we could know years in advance of cancer, hepatitis, or Alzheimer's.”

Another advantage would be large-scale diagnostics that could provide beneficial data about disease processes such as diabetes. "We don't know if it's genetic. The only way to find out is to test a lot of people,” said Prof. Stellacci. "The more we test with microarrays, the more we know about illnesses, and the more we can detect them.”

SuNS has applications beyond DNA microarrays. Materials both organic and inorganic (i.e., metal nanoparticles) can be made to assemble along a pattern comprised of DNA strands. This makes SuNS a versatile method that could be used to produce other complex nano-devices currently manufactured slowly and expensively: micro- and nano-fluidics channels, single-electron transistors, metallic wires, and optical biosensors.

A report on the technology was published in May 2005 in the online section of the journal Nano Letters.




Related Links:
Massachusetts Institute of Technology >

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.